{"id":1982,"date":"2018-12-11T16:05:32","date_gmt":"2018-12-11T21:05:32","guid":{"rendered":"http:\/\/parkinsonpost.com\/?p=1982"},"modified":"2018-12-11T16:05:32","modified_gmt":"2018-12-11T21:05:32","slug":"canadian-open-parkinson-network-funding-begins-collaboration-platform-to-accelerate-parkinsons-disease-research-and-knowledge-2","status":"publish","type":"post","link":"https:\/\/archiveparkinson.thedev.ca\/fr\/canadian-open-parkinson-network-funding-begins-collaboration-platform-to-accelerate-parkinsons-disease-research-and-knowledge-2\/","title":{"rendered":"Canadian Open Parkinson Network funding begins collaboration platform to accelerate Parkinson\u2019s disease research and knowledge"},"content":{"rendered":"

\"\"Parkinson Canada <\/strong>together with Brain Canada<\/strong> are pleased to announce the creation of the Canadian Open Parkinson Network<\/strong> (C-OPN). The $2\u00a0million Platform Grant is intended to support the initial development and maintenance of a large-scale research network that is built on the foundation of the established and successful Quebec Parkinson Network (QPN), and involve multiple provinces, in the field of Parkinson\u2019s disease and related disorders. Brain Canada receives financial support from Health Canada through the Canada Brain Research Fund.<\/p>\n

\u201cBrain Canada is pleased to be a partner with Parkinson Canada on the Canadian Open Parkinson Network. This program follows the establishment of the Canadian Open Neuroscience Platform, a national effort we initiated to link data across the country, and standardize how we collect, store and analyze this data. The Parkinson registry and database will create the first national platform to capture data from those living with Parkinson\u2019s, and make the data accessible to a wider number of researchers. The goal is to accelerate our already excellent Parkinson\u2019s research in Canada, resulting in better patient outcomes,\u201d\u00a0\u200e says Inez Jabalpurwala<\/strong>, President and CEO of Brain\u00a0Canada.<\/p>\n

Parkinson\u2019s disease affects over 100,000 Canadians, a number expected to increase substantially in the coming years. Through the important work performed and shared by researchers, the C-OPN will build capacity and increase awareness among all levels of government, healthcare professionals, the research community, health charities and the general public.<\/p>\n

Dr. Oury Monchi<\/strong>, PhD, has been appointed as Principal Investigator and Director of the C-OPN, which is a collaboration of the brightest minds in Parkinson\u2019s research in Canada today. Dr. Monchi holds the Tourmaline Oil Chair in Parkinson\u2019s disease, and is the Clinical Research Director at the Hotchkiss Brain Institute, Cumming School of Medicine at the University of Calgary, where he is also a professor in the Departments of Clinical Neurosciences and Radiology, Leader of the Movement Disorders Neuroteam and CaPRI, and Clinical Research Director at the Department of Clinical Neurosciences.<\/p>\n

\u201cThe Canadian Open Parkinson Network is a major initiative that will keep Canada at the leading edge of Parkinson\u2019s disease research. By building a strong, interconnected and collaborative network of researchers, physicians and people living with Parkinson\u2019s, we can work strategically to accelerate advancements in Parkinson\u2019s research and treatment,\u201d states Dr. Monchi.<\/p>\n

The Canadian Open Parkinson Network will include:<\/p>\n